Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Dec;110(4):1363–1368. doi: 10.1111/j.1476-5381.1993.tb13970.x

Effects of atrial natriuretic peptide and nitroprusside on isolated pulmonary resistance and conduit arteries from rats with pulmonary hypertension.

J C Wanstall 1, J S Thompson 1, A H Morice 1
PMCID: PMC2175877  PMID: 8306077

Abstract

1. The relaxant effects of atrial natriuretic peptide (ANP) and nitroprusside were studied on prostaglandin F2 alpha (PGF2 alpha)-contracted preparations of pulmonary resistance vessels (internal diameter 200-500 microns) and main pulmonary arteries taken from rats with pulmonary hypertension induced by monocrotaline (105 mg kg-1, s.c., 4 weeks previously). Control rats received saline. 2. In preparations from monocrotaline-treated rats, the potencies (negative log EC50) of ANP on resistance vessels (8.45) and main pulmonary arteries (8.25) were similar to those obtained in vessels from control rats (8.78 and 8.53 respectively), whereas those of nitroprusside were significantly less than in controls in both resistance vessels (7.13 compared with 7.63 in controls; three fold decrease in potency) and main pulmonary arteries (6.92 compared with 8.17 in controls; 18 fold decrease in potency). 3. On pulmonary resistance vessels from monocrotaline-treated rats, the maximum relaxant responses to ANP and nitroprusside, and also to pinacidil, were increased compared with controls, and reversal of the PGF2 alpha-induced contraction by these drugs was greater than 100%. In contrast, on main pulmonary arteries from monocrotaline-treated rats, the maximum relaxations to ANP and nitroprusside were not increased relative to controls, and reversal of PGF2 alpha was not greater than 100%.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
1363

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adnot S., Chabrier P. E., Andrivet P., Viossat I., Piquet J., Brun-Buisson C., Gutkowska Y., Braquet P. Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension. Am Rev Respir Dis. 1987 Oct;136(4):951–956. doi: 10.1164/ajrccm/136.4.951. [DOI] [PubMed] [Google Scholar]
  2. Altiere R. J., Olson J. W., Gillespie M. N. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension. J Pharmacol Exp Ther. 1986 Feb;236(2):390–395. [PubMed] [Google Scholar]
  3. Barer G. R., Cai Y. N., Russell P. C., Emery C. J. Reactivity and site of vasomotion in pulmonary vessels of chronically hypoxic rats: relation to structural changes. Am Rev Respir Dis. 1989 Nov;140(5):1483–1485. doi: 10.1164/ajrccm/140.5.1483. [DOI] [PubMed] [Google Scholar]
  4. Crawley D. E., Zhao L., Giembycz M. A., Liu S., Barnes P. J., Winter R. J., Evans T. W. Chronic hypoxia impairs soluble guanylyl cyclase-mediated pulmonary arterial relaxation in the rat. Am J Physiol. 1992 Sep;263(3 Pt 1):L325–L332. doi: 10.1152/ajplung.1992.263.3.L325. [DOI] [PubMed] [Google Scholar]
  5. Ignarro L. J., Kadowitz P. J. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol. 1985;25:171–191. doi: 10.1146/annurev.pa.25.040185.001131. [DOI] [PubMed] [Google Scholar]
  6. Jin H. K., Yang R. H., Thornton R. M., Chen Y. F., Jackson R., Oparil S. Atrial natriuretic peptide lowers pulmonary arterial pressure in hypoxia-adapted rats. J Appl Physiol (1985) 1988 Oct;65(4):1729–1735. doi: 10.1152/jappl.1988.65.4.1729. [DOI] [PubMed] [Google Scholar]
  7. McKenzie J. C., Tanaka I., Inagami T., Misono K. S., Klein R. M. Alterations in atrial and plasma atrial natriuretic factor (ANF) content during development of hypoxia-induced pulmonary hypertension in the rat. Proc Soc Exp Biol Med. 1986 Mar;181(3):459–463. doi: 10.3181/00379727-181-rc3. [DOI] [PubMed] [Google Scholar]
  8. Morice A. H., Pepke-Zaba J., Brown M. J., Thomas P. S., Higenbottam T. W. Atrial natriuretic peptide in primary pulmonary hypertension. Eur Respir J. 1990 Sep;3(8):910–913. [PubMed] [Google Scholar]
  9. Rapoport R. M., Murad F. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP. J Cyclic Nucleotide Protein Phosphor Res. 1983;9(4-5):281–296. [PubMed] [Google Scholar]
  10. Rogers T. K., Stewart A. G., Morice A. H. Effect of chronic hypoxia on rat pulmonary resistance vessels: vasodilatation by atrial natriuretic peptide. Clin Sci (Lond) 1992 Dec;83(6):723–729. doi: 10.1042/cs0830723. [DOI] [PubMed] [Google Scholar]
  11. Southerton J. S., Weston A. H., Bray K. M., Newgreen D. T., Taylor S. G. The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques. Naunyn Schmiedebergs Arch Pharmacol. 1988 Sep;338(3):310–318. doi: 10.1007/BF00173406. [DOI] [PubMed] [Google Scholar]
  12. Stewart A. G., Sheedy W., Thompson J. S., Morice A. H. Effects of SCH 34826, a neutral endopeptidase inhibitor, on hypoxic pulmonary vascular remodelling. Pulm Pharmacol. 1992 Jun;5(2):111–114. doi: 10.1016/0952-0600(92)90027-e. [DOI] [PubMed] [Google Scholar]
  13. Stewart A. G., Thompson J. S., Rogers T. K., Morice A. H. Atrial natriuretic peptide-induced relaxation of pre-constricted isolated rat perfused lungs: a comparison in control and hypoxia-adapted animals. Clin Sci (Lond) 1991 Aug;81(2):201–208. doi: 10.1042/cs0810201. [DOI] [PubMed] [Google Scholar]
  14. Tremblay J., Hamet P. Biochemical mechanisms of atrial natriuretic factor action. Can J Physiol Pharmacol. 1989 Sep;67(9):1124–1129. doi: 10.1139/y89-179. [DOI] [PubMed] [Google Scholar]
  15. Waldman S. A., Rapoport R. M., Murad F. Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. J Biol Chem. 1984 Dec 10;259(23):14332–14334. [PubMed] [Google Scholar]
  16. Wanstall J. C., Hughes I. E., O'Donnell S. R. Reduced relaxant potency of nitroprusside on pulmonary artery preparations taken from rats during the development of hypoxic pulmonary hypertension. Br J Pharmacol. 1992 Oct;107(2):407–413. doi: 10.1111/j.1476-5381.1992.tb12759.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wanstall J. C., O'Donnell S. R. Endothelin and 5-hydroxytryptamine on rat pulmonary artery in pulmonary hypertension. Eur J Pharmacol. 1990 Feb 6;176(2):159–168. doi: 10.1016/0014-2999(90)90524-a. [DOI] [PubMed] [Google Scholar]
  18. Wanstall J. C., O'Donnell S. R., Kay C. S. Increased relaxation by felodipine on pulmonary artery from rats with monocrotaline-induced pulmonary hypertension does not reflect functional impairment of the endothelium. Pulm Pharmacol. 1991;4(1):60–66. doi: 10.1016/0952-0600(91)90041-z. [DOI] [PubMed] [Google Scholar]
  19. Wanstall J. C., O'Donnell S. R. Responses to vasodilator drugs on pulmonary artery preparations from pulmonary hypertensive rats. Br J Pharmacol. 1992 Jan;105(1):152–158. doi: 10.1111/j.1476-5381.1992.tb14227.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Winter R. J., Meleagros L., Pervez S., Jamal H., Krausz T., Polak J. M., Bloom S. R. Atrial natriuretic peptide levels in plasma and in cardiac tissues after chronic hypoxia in rats. Clin Sci (Lond) 1989 Jan;76(1):95–101. doi: 10.1042/cs0760095. [DOI] [PubMed] [Google Scholar]
  21. Winter R. J., Zhao L., Krausz T., Hughes J. M. Neutral endopeptidase 24.11 inhibition reduces pulmonary vascular remodeling in rats exposed to chronic hypoxia. Am Rev Respir Dis. 1991 Dec;144(6):1342–1346. doi: 10.1164/ajrccm/144.6.1342. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES